In8Bio (INAB) Total Non-Current Liabilities (2020 - 2026)
In8Bio's Total Non-Current Liabilities was $1.13 million in Q2 2026, down 48.2% from $2.18 million a year earlier and down 14.9% from the prior quarter.
Powered by 
Analysis
In8Bio (INAB) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends
At the end of FY2025, Total Non-Current Liabilities at In8Bio came in at $1.56 million, down 53.8% from FY2024.
- Total Non-Current Liabilities shows a five-year compound annual growth rate of 147.0% (FY2020 to FY2025).
- In earlier years, Total Non-Current Liabilities was $3.38 million in FY2024 (+0.1%), $3.38 million in FY2023 (-24.7%), $4.49 million in FY2022 (+151.4%) and $1.78 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly Total Non-Current Liabilities since Q4 2020.
- Compared with a year earlier, Total Non-Current Liabilities has declined for five straight quarters, with an average decline of 36.5% over the last seven quarters.
- The best year-over-year quarter for Total Non-Current Liabilities over five years was Q2 2023 (growth of 185.8%); the worst was Q2 2022 (a decline of 96.3%).
- Per Business Quant data, INAB's Total Non-Current Liabilities in the three quarters before Q2 2026 was $1.33 million (Q1 2026), $1.56 million (Q4 2025) and $1.88 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.92 Bn |
| 10 | In8Bio | 25.89 Mn | 25.89 Mn | - | 1.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.13 Mn |
| Mar 31, 2026 | 1.33 Mn |
| Dec 31, 2025 | 1.56 Mn |
| Sep 30, 2025 | 1.88 Mn |
| Jun 30, 2025 | 2.18 Mn |
| Mar 31, 2025 | 3.04 Mn |
| Dec 31, 2024 | 3.38 Mn |
| Sep 30, 2024 | 3.74 Mn |
| Jun 30, 2024 | 4.12 Mn |
| Dec 31, 2023 | 3.38 Mn |
| Sep 30, 2023 | 3.76 Mn |
| Jun 30, 2023 | 4.14 Mn |
| Mar 31, 2023 | 4.14 Mn |
| Dec 31, 2022 | 4.49 Mn |
| Sep 30, 2022 | 3.92 Mn |
| Jun 30, 2022 | 1.45 Mn |
| Mar 31, 2022 | 1.64 Mn |
| Dec 31, 2021 | 1.78 Mn |
| Sep 30, 2021 | 4.10 Mn |
| Jun 30, 2021 | 38.80 Mn |
API Access
In8Bio Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=INAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "INAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=INAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();